Adam Bain, President of Global Revenue & Partnerships at Twitter, discusses how the acquisition of mobile-focused ad marketplace MoPub will benefit Twitter.» Read More
Ethan Kurzweil, Bessemer Venture Partners, provides insight on Amazon's $970 million acquisition of video game streaming company Twitch.
The "Squawk Box" news team discusses details of the pending merger between Burger King and Tim Horton, including Warren Buffett's role in the deal.
Burger King Worldwide confirmed plans to acquire Tim Hortons, with billionaire Warren Buffett helping to finance the deal.
CNBC's Catherine Boyle reports on whether Pfizer might make another bid for Astrazeneca three months after the collapse of its £69.4 billion ($115.14 billion) approach.
Amazon's acquisition of Twitch can help the firm to better engage consumers, says Edward Williams, Analyst at BMO Capital Markets.
The Fast Money traders share their final trades of the day.
The Fast Money traders take a look at today's biggest market movers.
The all-cash deal will give Amazon an extraordinarily popular streaming video arm—one that could actually rival Google's YouTube.
Daniel Mitchell, The Cato Institute, discusses if Burger King's potential purchase of Tim Hortons will open the floodgates for more tax inversions of U.S. companies.
CNBC's Sara Eisen reports Burger King is in talks to buy Tim Hortons.
CNBC's Jon Fortt reports Amazon has purchased Twitch for $970 million. Amazon expects the deal to close before the end of 2014.
CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.
Amazon is in talks to acquire Twitch, the live-streaming gaming network that Google had reportedly expressed an interest in buying, a tech blog said.
The companies confirmed late on Sunday that they were discussing a takeover of Tim Hortons by Burger King.
Burger King is in discussion to possibly acquire Tim Hortons, and there's talk the deal would be structured as a tax inversion. FMHR trader Jon Najarian and Josh Brown take their positions on the news.
Roche's deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech.
Switzerland's Roche is buying InterMune for $8.3 billion. CNBC's Meg Tirrell reports InterMune's Esbriet drug could draw more than $1 billion in annual revenue.
Drug giant Roche is buying biotech firm InterMune for $8.3 billion. CNBC's Jim Cramer discusses the lifesaving drug behind the wave of M&A deals.
Burger King is in talks to buy Canadian coffee chain Tim Hortons. CNBC's Jim Cramer breaks down the potential merger.
R.J. Hottovy, Morningstar, shares his thoughts on young consumers defecting to fast-casual restaurants like Chipotle, and Five Guys.
Get the best of CNBC in your inbox